BioSpace News Archive

Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has completed the previously announced divestiture of its Animal Health business to PetIQ (NASDAQ: PETQ) for $185 million.

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that are used to treat patients of all ages suffering from respiratory distress, announced today that it will release financial results for the second quarter of 2019 after the close of trading on Monday, July 29, 2019.

Satsuma Pharmaceuticals, Inc. (“Satsuma” or “the Company”), today announced that a poster describing pharmacokinetic (PK), safety and tolerability data from a Phase 1 trial of STS101 will be presented at the American Headache Society’s Annual Scientific Meeting convening in Philadelphia, PA on July 11-14, 2019.

Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its second quarter ended June 30, 2019 after the market closes on Thursday, July 25, 2019

Canopy Rivers Inc. is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation, has received approval of a licence amendment from Health Canada.

Innovative program, delivered by RQI Partners LLC, verifies CPR competence and improves quality and performance

Alfasigma USA, Inc. today announced it has acquired the brand ZELNORM, a prescription pharmaceutical treatment for irritable bowel syndrome with constipation (IBS-C), from Sloan Pharma S.à r.l., a subsidiary of US WorldMeds Holdings, LLC. Plans to relaunch ZELNORM in the United States are currently underway.

ChoiceOne Urgent Care in partnership with Gwinnett Medical Center would like to invite the public to family-friendly grand opening events starting Thursday, July 11 until the official opening on Monday, July 15.

CCA Industries, Inc. (OTC: “CAWW”) announced today its results for the second quarter and six months ended May 31, 2019, which can be found in the table below.

Seventure Partners, one of Europe’s leaders in financing innovation in Life sciences and associated industries, announces the launch of Sport & Performance Capital™, a new fund dedicated to supporting innovation in the sport and wellness industries. With a final target of €80 million, the venture fund will invest in startup companies and growing SMEs furthering physical activity to help promote health and physical fitness.